Ghrelin's Effects on Proinflammatory Cytokine Mediated Apoptosis and Their Impact on β-Cell Functionality

International Journal of Endocrinology

Volumn 2015, Issue , 2015, Pages

  Diaz Ganete, Antonia ^a   Baena Nieto, Gloria ^a,b   Lomas Romero, Isabel M ^a,c   Lopez Acosta, Jose Francisco ^a,d   Cozar Castellano, Irene ^d   Medina, Francisco ^a,e   Segundo, Carmen ^a,e   Lechuga Sancho, Alfonso M ^a  

^a HOSPITAL UNIVERSITARIO PUERTA DEL MAR   (Spain)

^b Department of Endocrinology and Nutrition Jerez de la Frontera General Hospital   (Spain)

^c Andalusian Cellular Reprogramming Laboratory   (Spain)

^d UNIVERSITY OF VALLADOLID   (Spain)

^e UNIVERSITY OF CÁDIZ   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 8; CASPASE 9; GAMMA INTERFERON; GHRELIN; INTERLEUKIN 1BETA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN BCL 2; PROTEIN KINASE B; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL METABOLISM; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE RELEASE; DOWN REGULATION; ENDOPLASMIC RETICULUM STRESS; INSULIN RELEASE; MALE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; TURNOVER TIME;

EID: 84938153187     PISSN: 16878337     EISSN: 16878345     Source Type: Journal    
DOI: 10.1155/2015/235727     Document Type: Article

References (45)

1. M. Kojima, H. Hosoda, Y. Date, M. Nakazato, H. Matsuo, and K. Kangawa, "Ghrelin is a growth-hormone-releasing acylated peptide from stomach, " Nature, vol. 402, no. 6762, pp. 656-660, 1999.
2. A. Inui, A. Asakawa, C. Y. Bowers et al., "Ghrelin, appetite, and gastric motility: the emerging role of the stomach as an endocrine organ, " The FASEB Journal, vol. 18, no. 3, pp. 439-456, 2004.
3. T. Sato, Y. Nakamura, Y. Shiimura, H. Ohgusu, K. Kangawa, and M. Kojima, "Structure, regulation and function of ghrelin, " Journal of Biochemistry, vol. 151, no. 2, pp. 119-128, 2012.
4. G. Bottazzo, A. Florin-Christensen, and D. Doniach, "ISLET-CELL ANTIBODIES IN DIABETES MELLITUS WITH AUTOIMMUNE POLYENDOCRINE DEFICIENCIES, " The Lancet, vol. 304, no. 7892, pp. 1279-1283, 1974.
5. A. C. Maccuish, W. J. Irvine, E. W. Barnes, and L. J. P. Duncan, "Antibodies to pancreatic islet cells in insulin-dependent diabetics with coexistent autoimmune disease, " The Lancet, vol. 304, no. 7896, pp. 1529-1531, 1974.
6. D. L. Eizirik, M. L. Colli, and F. Ortis, "The role of infammation in insulitis and beta-cell loss in type 1 diabetes, " Nature Reviews Endocrinology, vol. 5, no. 4, pp. 219-226, 2009.
7. S. Cottet, P. Dupraz, F. Hamburger, W. Dolci, M. Jaquet, and B. Torens, "cFLIP protein prevents tumor necrosis factor-β-mediated induction of caspase-8-dependent apoptosis in insulin-secreting Tc-Tet cells, " Diabetes, vol. 51, no. 6, pp. 1805-1814, 2002.
8. L. G. Grunnet, R. Aikin, M. F. Tonnesen et al., "Proinfamma-tory cytokines activate the intrinsic apoptotic pathway in β-cells, " Diabetes, vol. 58, no. 8, pp. 1807-1815, 2009.
9. C. Kantari and H. Walczak, "Caspase-8 and bid: caught in the act between death receptors and mitochondria, " Biochimica et Biophysica Acta, vol. 1813, no. 4, pp. 558-563, 2011.
10. M. C. Akerfieldt, J. Howes, J. Y. Chan et al., "Cytokine-induced/3-cell death is independent of endoplasmic reticulum stress signaling, " Diabetes, vol. 57, no. 11, pp. 3034-3044, 2008.
11. S. Vasu, N. H. McClenaghan, J. T. McCluskey, and P. R. Flatt, "Mechanisms of toxicity by proinfammatory cytokines in a novel human pancreatic beta cell line, 1.1B4, " Biochimica et Biophysica Acta-General Subjects, vol. 1840, no. 1, pp. 136-145, 2014.
12. M. Cnop, N. Welsh, J.-C. Jonas, A. Jorns, S. Lenzen, and D. L. Eizirik, "Mechanisms of pancreatic/3-cell death in type 1 and type 2 diabetes: many diferences, few similarities, " Diabetes, vol. 54, supplement 2, pp. S97-S107, 2005.
13. I. Kharroubi, L. Ladriere, A. K. Cardozo, Z. Dogusan, M. Cnop, and D. L. Eizirik, "Free fatty acids and cytokines induce pancreatic/3-cell apoptosis by diferent mechanisms: role of nuclear factor-/cB and endoplasmic reticulum stress, " Endocrinology, vol. 145, no. 11, pp. 5087-5096, 2004.
14. A. K. Cardozo, F. Ortis, J. Storling et al., "Cytokines downreg-ulate the sarcoendoplasmic reticulum pump Ca2+ ATPase 2b and deplete endoplasmic reticulum Ca2+, leading to induction of endoplasmic reticulum stress in pancreatic/3-cells, " Diabetes, vol. 54, no. 2, pp. 452-461, 2005.
15. I. Mehmeti, S. Lenzen, and S. Lortz, "Modulation of Bcl-2-related protein expression in pancreatic beta cells by proinfammatory cytokines and its dependence on the antioxida-tive defense status, " Molecular and Cellular Endocrinology, vol. 332, no. 1-2, pp. 88-96, 2011.
16. B. Kutlu, A. K. Cardozo, M. I. Darville et al., "Discovery of gene networks regulating cytokine-induced dysfunction and apoptosis in insulin-producing INS-1 cells, " Diabetes, vol. 52, no. 11, pp. 2701-2719, 2003.
17. R. Granata, F. Settanni, L. Biancone et al., "Acylated and unacylated ghrelin promote proliferation and inhibit apoptosis of pancreatic/3-cells and human islets: involvement of 3, 5-cyclic adenosine monophosphate/protein kinase A, extracellular signal-regulated kinase 1/2, and phosphatidyl inositol 3-kinase/Akt signaling, " Endocrinology, vol. 148, no. 2, pp. 512-529, 2007
18. M. Kerem, B. Salman, S. Ozsoy et al., "Exogenous ghrelin enhances endocrine and exocrine regeneration in pancreatec-tomized rats, " Journal of Gastrointestinal Surgery, vol. 13, no. 4, pp. 775-783, 2009.
19. T. Irako, T. Akamizu, H. Hosoda et al., "Ghrelin prevents development of diabetes at adult age in streptozotocin-treated newborn rats, " Diabetologia, vol. 49, no. 6, pp. 1264-1273, 2006.
20. R. Granata, M. Volante, F. Settanni et al., "Unacylated ghrelin and obestatin increase islet cell mass and prevent diabetes in streptozotocin-treated newborn rats, " Journal of Molecular Endocrinology, vol. 45, no. 1, pp. 9-17, 2010.
21. R. Granata, F. Settanni, M. Julien et al., "Des-acyl ghrelin fragments and analogues promote survival of pancreatic j3-cells and human pancreatic islets and prevent diabetes in streptozotocin-treated rats, " Journal of Medicinal Chemistry, vol. 55, no. 6, pp. 2585-2596, 2012.
22. J. A. Corbett and M. L. McDaniel, "Intraislet release of inter-leukin 1 inhibits j3 cell function by inducing j3 cell expression of inducible nitric oxide synthase, " Journal of Experimental Medicine, vol. 181, no. 2, pp. 559-568, 1995.
23. A. Merglen, S. Teander, B. Rubi, G. Chafard, C. B. Wollheim, and P. Maechler, "Glucose sensitivity and metabolism-secretion coupling studied during two-year continuous culture in INS-1E insulinoma cells, " Endocrinology, vol. 145, no. 2, pp. 667-678, 2004.
24. M. Blandino-Rosano, G. Perez-Arana, J. M. Mellado-Gil, C. Segundo, and M. Aguilar-Diosdado, "Anti-proliferative effect of pro-infammatory cytokines in cultured cells is associated with extracellular signal-regulated kinase 1/2 pathway inhibition: protective role of glucagon-like peptide-1, " Journal of Molecular Endocrinology, vol. 41, no. 1-2, pp. 35-44, 2008.
25. J. M. Mellado-Gil and M. Aguilar-Diosdado, "High glucose potentiates cytokine-and streptozotocin-induced apoptosis of rat islet cells: effect on apoptosis-related genes, " Journal of Endocrinology, vol. 183, no. 1, pp. 155-162, 2004.
26. M. L. McDaniel, J. R. Colca, N. Kotagal, and P. E. Lacy, "A subcellular fractionation approach for studying insulin release mechanisms and calcium metabolism in islets of Langerhans, " Methods in Enzymology, vol. 98, pp. 182-200, 1983.
27. C. W. Lindsley, "The Akt/PKB family of protein kinases: a review of small molecule inhibitors and progress towards target validation: a 2009 update, " Current Topics in Medicinal Chemistry, vol. 10, no. 4, pp. 458-477, 2010.
28. A. K. Cardozo, M. Kruhøfer, R. Leeman, T. Ørntof, and D. L. Eizirik, "Identifcation of novel cytokine-induced genes in pancreatic β-cells by high-density oligonucleotide arrays, " Diabetes, vol. 50, no. 5, pp. 909-920, 2001.
29. W. D'Hertog, L. Overbergh, K. Lage et al., "Proteomics analysis of cytokine-induced dysfunction and death in insulin-producing INS-1E cells: new insights into the pathways involved, " Molecular and Cellular Proteomics, vol. 6, no. 12, pp. 2180-2199, 2007.
30. M. Lopes, B. Kutlu, M. Miani et al., "Temporal profling of cytokine-induced genes in pancreatic β-cells by meta-analysis and network inference, " Genomics, vol. 103, no. 4, pp. 264-275, 2014.
31. L. Li, W. El-Kholy, C. J. Rhodes, and P. L. Brubaker, "Glucagon-like peptide-1 protects beta cells from cytokine-induced apop-tosis and necrosis: role of protein kinase B, " Diabetologia, vol. 48, no. 7, pp. 1339-1349, 2005.
32. Y. Zhang, B. Ying, L. Shi et al., "Ghrelin inhibit cell apoptosis in pancreatic cell line HIT-T15 via mitogen-activated protein kinase/phosphoinositide 3-kinase pathways, " Toxicology, vol. 237, no. 1-3, pp. 194-202, 2007.
33. F. Ortis, A. K. Cardozo, D. Crispim, J. Störling, T. Mandrup-Poulsen, and D. L. Eizirik, "Cytokine-induced proapoptotic gene expression in insulin-producing cells is related to rapid, sustained, and nonoscillatory nuclear factor-B activation, " Molecular Endocrinology, vol. 20, no. 8, pp. 1867-1879, 2006.
34. J. Størling, J. Binzer, A. K. Andersson et al., "Nitric oxide contributes to cytokine-induced apoptosis in pancreatic beta cells via potentiation of JNK activity and inhibition of Akt, " Diabetologia, vol. 48, no. 10, pp. 2039-2050, 2005.
35. I. Santin, F. Moore, M. L. Colli et al., "PTPN2, a candidate gene for type 1 diabetes, modulates pancreatic β-cell apoptosis via regulation of the BH3-only protein bim, " Diabetes, vol. 60, no. 12, pp. 3279-3288, 2011.
36. F. Moore, I. Santin, T. C. Nogueira et al., "The transcription factor C/EBP delta has anti-apoptotic and anti-infammatory roles in pancreatic beta cells, " PLoS ONE, vol. 7, no. 2, Article ID e31062, 2012.
37. W. Wang, D. Zhang, H. Zhao et al., "Ghrelin inhibits cell apoptosis induced by lipotoxicity in pancreatic β-cell line, " Regulatory Peptides, vol. 161, no. 1-3, pp. 43-50, 2010.
38. X. Zhou and C. Xue, "Ghrelin inhibits the development of acute pancreatitis and nuclear factor kappaB activation in pancreas and liver, " Pancreas, vol. 38, no. 7, pp. 752-757, 2009.
39. G. D. Pavitt and D. Ron, "New insights into translational regulation in the endoplasmic reticulum unfolded protein response, " Cold Spring Harbor Perspectives in Biology, vol. 4, no. 6, 2012.
40. M. Bando, H. Iwakura, H. Ariyasu et al., "Transgenic overex-pression of intraislet ghrelin does not afect insulin secretion or glucose metabolism in vivo, " The American Journal of Physiology-Endocrinology and Metabolism, vol. 302, no. 4, pp. E403-E408, 2012.
41. A. M. Wren, C. J. Small, C. R. Abbott et al., "Ghrelin causes hyperphagia and obesity in rats, " Diabetes, vol. 50, no. 11, pp. 2540-2547, 2001.
42. K. Dezaki, H. Sone, and T. Yada, "Ghrelin is a physiological regulator of insulin release in pancreatic islets and glucose homeostasis, " Pharmacology and Terapeutics, vol. 118, no. 2, pp. 239-249, 2008.
43. S. Sangiao-Alvarellos and F. Cordido, "Effect of ghrelin on glucose-insulin homeostasis: therapeutic implications, " International Journal of Peptides, vol. 2010, Article ID 234709, 25 pages, 2010.
44. F. Cordido, "Insulin regimens in type 2 diabetes, " The New England Journal of Medicine, vol. 362, no. 10, p. 960, 2010.
45. M. Bando, H. Iwakura, H. Ariyasu et al., "Overexpression of intraislet ghrelin enhances β-cell proliferation after strepto-zotocin-induced β-cell injury in mice, " The American Journal of Physiology-Endocrinology and Metabolism, vol. 305, no. 1, pp. E140-E148, 2013.